Toward Personalized Medicine for Kidney Transplant Recipients

UC San Francisco is the lead institution on a new seven-year, $17 million multicenter study funded by the National Institutes of Health to determine if certain immune system cells and/or a drug now used for treating rheumatoid arthritis can be effective in improving and maintaining the long-term health of kidney transplant recipients.
Source: UCSF Medical Center - Category: Universities & Medical Training Authors: Source Type: news